SMAD2 and Myocardial fibrosis: This balance and the unaltered levels of phosphorylated SMAD2/3 are also in line with the absence of myocardial fibrosis, as BMPR2 is an antagonist in the TGFβ fibrotic pathway, preventing fibrosis (Goumans et al., 2008).